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SUMMARY 
How mitochondrial DNA (mtDNA) replication is terminated, and the newly formed 
genomes are separated, remains unknown. We here demonstrate that the 
mitochondrial isoform of topoisomerase 3α (Top3α) has been repurposed from the 
nuclear Holliday junction-dissolving BTR complex to fulfil this function. At the end 
of mtDNA replication a hemicatenane is formed at the origin of H-strand replication 
and Top3α is essential for resolving this structure. Decatenation is a prerequisite for 
separation of the segregating unit of mtDNA, the nucleoid, within the mitochondrial 
network. The importance of this process is highlighted in a patient with mitochondrial 
disease caused by biallelic pathogenic variants in TOP3A, characterised by muscle-
restricted mtDNA deletions and chronic progressive external ophthalmoplegia 
(CPEO) plus syndrome. Our work establishes Top3α as an essential component of the 
mtDNA replication machinery and as the first component of the mtDNA separation 
machinery. 
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INTRODUCTION 
 
The mammalian mitochondrial genome (mtDNA) is maintained at thousands of 
copies per cell, and is packaged into nucleoprotein complexes termed nucleoids. The 
majority of nucleoids contain a single mtDNA molecule compacted by mitochondrial 
transcription factor A (TFAM) via cross-strand binding (Kukat et al., 2015; Kukat et 
al., 2011). Nucleoids are readily visible by fluorescence microscopy, where they 
appear as punctate foci distributed throughout the mitochondrial network (Satoh and 
Kuroiwa, 1991). The mitochondrial network is itself spread across the cytosol and is 
highly dynamic, with its morphology modulated by the opposing processes of fission 
and fusion. Recent data suggest that the segregation of newly-replicated nucleoids is 
coupled to mitochondrial fission at endoplasmic reticulum contact sites, which serves 
to distribute nucleoids throughout the mitochondrial network (Lewis et al., 2016). The 
protein products of mtDNA perform essential roles in the respiratory chain, and 
defects of mitochondrial fission and fusion are associated with improper nucleoid 
distribution and heterogeneity of membrane potential, as well as mtDNA instability 
(Friedman and Nunnari, 2014). The importance of these processes is highlighted by 
the fact that pathogenic variants in nuclear genes involved in the maintenance and 
replication of mtDNA are associated with an extensive spectrum of clinical 
phenotypes ranging from severe encephalopathy in childhood, to late-onset 
progressive external ophthalmoplegia (PEO), ataxia and myopathy. Such disorders of 
mtDNA maintenance manifest as either mtDNA depletion (quantitative) syndromes or 
multiple mtDNA deletion (qualitative) disorders. Whilst at least 17 nuclear-encoded 
genes have been reported to be associated with adult-onset PEO and muscle-restricted 
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mtDNA deletions (Viscomi and Zeviani, 2017), the underlying nuclear genetic defect 
remains undetermined in a sizeable number of cases. 
 
The mitochondrial genome is highly compact and has only one major non-coding 
region (NCR), which contains the origin of heavy (leading) strand DNA synthesis, 
OriH, and the two transcription promoters, LSP and HSP (Gustafsson et al., 2016). A 
proportion of mtDNA molecules maintain a stable D-loop structure spanning much of 
the NCR, with the 5ʹ ends of the additional linear strand (7S DNA) lying at a cluster 
of sites around OriH. The principal site of light (lagging) strand DNA synthesis, OriL, 
is positioned in a cluster of tRNA genes approximately 11 kb from OriH, and a 
substantial delay therefore occurs between the initiation of leading and lagging strand 
replication (Gustafsson et al., 2016). Although the mechanisms of mtDNA replication 
have been studied in detail, little is known about how newly synthesised mtDNA 
molecules are separated and segregated within the mitochondrial network after the 
completion of replication. Early pioneering EM studies of human mtDNA 
preparations identified catenanes linked together by X-type branches, which were 
postulated to have been formed during the completion of mtDNA replication (Hudson 
and Vinograd, 1967) but the relevant protein factors have remained unidentified. 
 
Catenated DNA forms can be unlinked by certain classes of topoisomerases, which 
contribute crucial activities during replication, transcription, chromosome segregation 
and recombination by creating transient breaks in the DNA backbone to alter DNA 
topology. Type I topoisomerases cleave one DNA strand to allow strand passage, 
whereas type II enzymes cleave both strands. Type II topoisomerases are thought to 
be the major factors that remove catenation links during DNA replication in the 
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eukaryotic nucleus (Pommier et al., 2016). Mammalian mitochondria possess two 
type I topoisomerases: a dedicated type IB enzyme, Top1mt (Zhang et al., 2001), and 
Top3α, a type IA enzyme that shows dual nuclear and mitochondrial localisation 
(Wang et al., 2002). Top1mt is thought to act as a DNA 'swivel' to relieve torsional 
strain during DNA replication and/or transcription, consistent with the mechanism of 
type IB enzymes (Stewart et al., 1998). A mouse knockout of the Top1mt gene is 
viable, although displays signs of mitochondrial dysfunction and shows altered 
mtDNA supercoiling (Douarre et al., 2012; Zhang et al., 2014). Type IA 
topoisomerases, in contrast, operate by an enzyme-bridged strand passage mechanism 
that permits distinct topological transformations depending upon the substrate: if the 
two strands are part of the same, hypernegatively supercoiled, DNA duplex then the 
result is relaxation (Plank et al., 2005), whereas if the substrate is interlinked ssDNA 
circles then the result is decatenation (Yang et al., 2010). Top3α contains an N-
terminal mitochondrial targeting sequence (MTS) that directs a proportion of the 
protein pool to mitochondria (Wang et al., 2002), but the functional role of this 
isoform in mtDNA metabolism has not been addressed. The nuclear isoform of 
Top3α forms a complex with the helicase BLM and the two OB-fold proteins RMI1 
and RMI2, which together catalyse the 'dissolution' of double Holliday junctions to 
produce noncrossover products, in a reaction that is stimulated by RMI1 and RMI2 
(Sarbajna and West, 2014). 
 
Previous reports have also identified two Type II topoisomerases in mitochondria: 
Top2α (Zhang et al., 2014), and Top2β, either in a truncated form (Low et al., 2003) 
or in full-length form (Zhang et al., 2014). Neither Top2α nor Top2β possess a 
detectable MTS, and it is unclear how their mitochondrial localisation would be 
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achieved. In contrast, the mitochondrial localisation of Top1mt and Top3α is 
supported by proteomic and bioinformatic studies (Calvo et al., 2016; Rhee et al., 
2013), in addition to the presence of targeting sequences.  
 
In the present work, we set out to identify enzymes required for separation of mtDNA 
molecules after the completion of DNA replication. We identify the mitochondrial 
isoform of Top3α as being essential for mtDNA separation and demonstrate that the 
loss of this enzyme leads to the formation of catenated mtDNA species, reminiscent 
of the mtDNA dimers described by the Vinograd laboratory 50 years ago (Hudson 
and Vinograd, 1967). We characterise the termination structure as a hemicatenane, 
consistent with the unorthodox use of Top3α, a type IA topoisomerase, for separation 
of newly replicated mtDNA molecules. We believe that our work provides a starting 
point for future investigations into the molecular mechanisms linking mtDNA 
separation to mtDNA segregation within the dynamic mitochondrial network. 
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RESULTS 
 
Top3α  is required for mtDNA maintenance 
After completion of DNA replication in bacteria, topoisomerases are required for 
removal of catenation links to separate sister chromosomes. It is not known whether 
topoisomerases are involved in genome separation in mammalian mitochondria. To 
address this point, we investigated the functional role of three topoisomerases with 
reported dual nuclear and mitochondrial localization: Top2α, Top2β, and Top3α. A 
fourth dedicated mitochondrial topoisomerase, Top1mt, has been extensively studied 
in the past (Pommier et al., 2016). We first assessed the mitochondrial localization of 
Top2α, Top2β, and Top3α by preparing highly purified mitochondrial and mitoplast 
fractions using differential centrifugation and sucrose gradient centrifugation (Fig. 
1A). Blotting of marker proteins histone H3 (nucleus), TFAM (mitochondrial matrix) 
and AIF (apoptosis inducing factor; intermembrane space) confirmed the purity of 
fractions. Consistent with a previous report (Wang et al., 2002), our analysis 
demonstrated that a proportion of the cellular pool of Top3α localises to the 
mitochondrial matrix. However, in contrast to previous reports (Zhang et al., 2014) 
we were unable to detect either Top2α or Top2β in our mitochondrial preparations. 
 
We next studied how loss of topoisomerase activity affects mtDNA levels and 
topology using siRNA in cultured cells. Efficient depletion of protein levels was 
confirmed using western blotting of cell lysates (Fig. 1B). The depletion efficiency of 
Top1mt was assessed in mitochondrial lysates (Fig. 1C) due to antibody limitations. 
Knockdown of Top3α, but not Top1mt, Top2α, or Top2β, caused an apparent 
depletion of mtDNA copy number (Fig. 1D,E), indicating a defect in mtDNA 
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maintenance. In Top3α depleted cells we also observed a reduction in the level of 7S 
DNA, the linear strand of the mitochondrial D-loop (Fig 1D, lanes 3 and 4). 
We next studied how loss of Top3α affects mtDNA topology. To this end, intact 
mtDNA was separated on agarose gels and detected by Southern blotting. In wild type 
cells, mtDNA is present as relaxed open circles, as well as variously supercoiled 
forms (Fig 1F, lanes 3 and 4). Loss of Top3α, but not Top1mt, Top2α, or Top2β, 
resulted in a profound loss of monomeric mtDNA forms (Fig. 1F, lanes 5 and 6), 
suggesting that loss of Top3α may induce the formation of higher-order mtDNA 
structures. 
 
The effect of Top3α depletion upon mtDNA replication was additionally assessed 
using 2D agarose gel electrophoresis, which revealed that depletion of Top3α 
produces a pronounced and genome-wide replication stalling phenotype (Fig. S1), 
consistent with the loss of mtDNA copy number in these cells. 
 
Mitochondrial Top3α  functions independently of the BTR complex 
In the nucleus, Top3α is a subunit of the BTR complex together with the helicase 
BLM and the OB-fold proteins RMI1 and RMI2. Of these proteins only Top3α was 
detectable in our mitochondrial preparations, whereas BLM, RMI1 and RMI2 were 
not (Fig. 2A). To address if the observed mtDNA maintenance defect associated with 
loss of Top3α was secondary to its role in the nuclear BTR complex, we used siRNA 
to deplete BLM, RMI1, and RMI2. Efficient depletion of protein levels was 
confirmed using western blotting of cell lysates (Fig. 2B). Dual-targeted proteins 
typically produce two separable protein products, in which the shorter isoform 
represents the mitochondrial protein following cleavage of the MTS by the 
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mitochondrial protein peptidase (Chacinska et al., 2009). Interestingly, whereas 
knockdown of RMI1 caused a destabilisation of the longer nuclear isoform of Top3α, 
the processed mitochondrial isoform was unaffected, supporting the notion that 
mitochondrial Top3α functions independently of the nuclear BTR complex (Fig. 2B, 
lanes 5 and 6). Furthermore, knockdowns of BLM, RMI1 or RMI2 did not cause 
depletion of mtDNA (Fig. 2C), of alteration of mtDNA topology (Fig. 2D), 
demonstrating that loss of mtDNA was not secondary nuclear effects caused by loss 
of the BTR complex.   
 
Loss of Top3α  induces mtDNA catenane formation 
We next investigated the effects of Top3α depletion upon mtDNA conformation 
using electron microscopy (EM). As expected, mtDNA isolated from cells treated 
with control siRNA was predominantly in monomeric relaxed circular (Fig. 3A) or 
monomeric supercoiled (Fig. 3B) forms. In contrast, mtDNA from Top3α-depleted 
cells was present as large catenated networks. The catenated species appeared as 
assemblies of circular DNA molecules linked together at a single central point, with 
only a small proportion of monomeric mtDNA remaining (Fig. 3C,D).  
 
Following the observation that intact mtDNA from Top3α depleted cells could not be 
separated on agarose gels (Fig. 1F), we decided to further characterise these structures 
by subjecting the intact mtDNA to various enzymatic treatments prior to gel 
separation and detection by Southern blotting. When mtDNA from Top3α depleted 
cells was treated with either S1 nuclease (an ssDNA-specific nuclease) or the branch-
cutting enzyme T7 endonuclease I, forms of mtDNA, migrating as the full length, 
linearized mitochondrial genome, were released (Fig. 3E). The fact that single-
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stranded cutters can resolve these catenanes suggested that they were partially single-
stranded, for instance a hemicatenated structure in which only one strand of one 
double-stranded DNA molecule is interlinked with one strand of another double-
stranded DNA molecule. Such a structure is also the expected final substrate for 
topoisomerase III during double Holliday junction dissolution (Cejka et al., 2010). 
We were unable to release the catenated species by treatment with purified human or 
prokaryotic type II topoisomerases (Fig. S2A,B), consistent with the notion that the 
structures were not formed by linked, fully double-stranded, circular mtDNA 
molecules. In EM preparations, longer tracts of ssDNA can be revealed by incubation 
with a single-strand binding protein (SSB), which visibly coats ssDNA. Incubation of 
mtDNA with E. coli SSB did not reveal significant tracts of ssDNA, further 
suggesting that the catenated mtDNA species are predominantly composed of fully 
replicated dsDNA and only contain short ssDNA stretches, rendering them sensitive 
to S1 nuclease (Fig. S2C,D). 
 
To verify that the loss of Top3α was directly responsible for the accumulation of high 
molecular weight mtDNA species, we expressed an siRNA-resistant version of the 
full-length Top3α protein and investigated if it could rescue the effect of endogenous 
Top3α gene knockdown in HEK293 cells (Fig. S3A,B). The full length, wild-type, 
siRNA resistant Top3α rescued the accumulation of high molecular weight mtDNA 
species, and this capacity was lost when either the catalytic tyrosine residue was 
mutated (Y362F) or the mitochondrial-targeting signal was eliminated.  
 
Top3α  and Top1mt display synergistic effects on mtDNA copy number but not 
catenation 
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Under normal conditions, loss of Top1mt has only mild effects on mtDNA 
maintenance. Furthermore, depletion of Top1mt only led to a small increase of 
catenated species, which were smaller than those seen in Top3α depleted cells, and 
not of a consistent structure (Fig. S3C-E). We simultaneously depleted Top3α and 
Top1mt to assess whether these two proteins may cooperate in mtDNA maintenance. 
Indeed, when both topoisomerases were depleted we observed a profound and 
synergistic depletion of mtDNA copy number, and an apparent total loss of 7S DNA 
(Fig. S3F,G). Visualisation of mtDNA from Top3α/Top1mt depleted cells by EM 
found the presence of catenated structures very similar to those seen in Top3α 
depleted cells (Fig. 3F). In addition, we also observed an increased number of late 
replication intermediates, suggesting a strong replication stalling phenotype (Fig. 
3G,H), consistent with the loss of mtDNA copy number. Quantification of monomeric 
and catenated mtDNA forms found no difference between the proportion of catenated 
mtDNA in Top3α/Top1mt depleted cells compared with Top3α depleted cells (Fig. 
3I). This suggests that the loss of Top1mt in combination with the loss of Top3α has 
an additive inhibitory effect upon replication fork progression but not upon mtDNA 
decatenation.  
 
Loss of Top3α  perturbs nucleoid separation and distribution within the 
mitochondrial network 
We next used confocal microscopy to visualize the effects of Top3α depletion upon 
mtDNA separation and segregation. Cells were stained with anti-DNA antibodies to 
detect the mtDNA nucleoid, and with antibodies against the outer mitochondrial 
membrane protein TOM20 to stain the mitochondrial network. In control siRNA 
treated cells, nucleoids appeared as a punctate pattern spread throughout the 
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cytoplasm, which co-localised with the mitochondrial network (Fig. 4A). In cells 
depleted of Top3α, there was a noticeable change in nucleoid size and distribution, 
with cells containing fewer, larger nucleoids. This loss of nucleoid number was 
exacerbated in cells depleted of both Top3α and Top1mt in combination, consistent 
with the loss of mtDNA copy number in these cells. Quantification of nucleoid 
numbers found that Top3α depletion induced a decrease of approximately 70 % in the 
number of nucleoids per cell, increasing to 83 % in cells depleted of both Top3α and 
Top1mt (Fig. 4C). Depletion of RMI1 did not appear to affect either nucleoid size or 
number, confirming that the observed effect of Top3α depletion was due to the 
mitochondrial isoform of Top3α. We next used gated stimulated emission depletion 
(g-STED) super-resolution microscopy to make quantitative measurements of 
nucleoid size. STED is preferable for such measurements because the diameter of the 
nucleoid, at approximately 100 nm, is below the diffraction barrier of conventional 
confocal microscopy. Indeed, application of g-STED to DNA-stained cells depleted 
of Top3α permitted the resolution of apparently single DNA structures in confocal 
images into multiple juxtaposed structures (Fig. 4B). Calibration of the microscope 
using fluorescent DNA origamis confirmed that the resolution was sufficient for 
quantitative nucleoid measurement under the conditions used (Fig. S4A,B). 
Measurement of nucleoid diameter in control siRNA treated cells confirmed the 
previously determined size of approximately 100 nm (Fig. 4D), corresponding to one 
mtDNA molecule compacted with proteins (Kukat et al., 2011). In contrast, cells 
depleted of Top3α showed a greatly enlarged mean nucleoid diameter of 
approximately 170 nm. This effect was also apparent, albeit at lower resolution, from 
confocal images of the same cells (Fig. S4C). Top3α depleted cells also showed a 
greatly enlarged range of nucleoid sizes, extending from around 100 nm up to 
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approximately 350-400 nm (Fig. S4D). The fact that these structures could not be 
resolved at the resolution permitted by g-STED implies that they represent multiple 
physically conjoined mtDNA genomes, consistent with the structures observed using 
EM (Fig. 3). Top3α-mediated DNA separation is therefore required for nucleoid 
segregation within the mitochondrial network. 
 
Catenane formation is centred around OriH 
Many of the catenanes observed in Top3α-depleted cells (Fig. 3) were joined through 
a single central point. This observation suggested that Top3α-mediated mtDNA 
decatenation is centred at a specific genomic region. Since mtDNA replication is 
initiated in the NCR and is unidirectional, we hypothesised that separation of fully 
replicated genomes would also occur in this region. To address this possibility, 
mtDNA from cells depleted of Top3α or Top1mt was cleaved with restriction 
enzymes to create a series of fragments of different lengths (between 3,526 and 
12,728 bp) containing the replication origin OriH (Fig. 5A). Ethidium bromide was 
included in the restriction digests to inhibit thermal branch migration of cleaved 
interlinked molecules (Harmon et al., 1999). After agarose gel separation, the 
fragments were detected by Southern blotting using a probe against the position 
16,262 to 128, located immediately downstream of OriH. mtDNA from either control 
siRNA treated cells or Top1mt-depleted cells produced a pattern of OriH-containing 
fragments of the expected sizes. However, when mtDNA isolated from Top3α 
depleted cells was analysed we consistently observed an additional band that migrated 
at approximately twice the expected fragment size (Fig. 5B). This band was present 
for all combinations of restriction enzymes that spanned the NCR, and could also be 
generated from high-level expression of catalytically inactive Top3α in HEK cells 
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(Fig S5), presumably as a dominant-negative effect. As we had observed from EM 
experiments that combined depletion of Top1mt and Top3α led to the formation of 
higher levels of catenated species, we repeated our analysis using mtDNA isolated 
from Top3α/Top1mt depleted cells. In these cells, we observed even higher levels of 
the slower migrating band (Fig. 5C). We speculated that the higher molecular weight 
band could correspond to two mtDNA fragments linked together via a hemicatenane, 
as fully catenated molecules would be resolved by restriction enzyme cleavage. In 
support of this notion, S1 nuclease treatment caused specific depletion of the slower 
migrating species, without affecting the shorter fragment (Fig. 5C). To further verify 
our interpretation, we used EM to visualise restricted mtDNA from Top3α/Top1mt 
depleted cells.  As expected, we detected a large proportion of X-shaped DNA 
molecules, corresponding to two mtDNA genomes being held together through a 
single junction (Fig. 5D,E). By measuring the length of the DNA arms from 
overlapping restriction fragments, we found that the junction site frequently maps to 
the OriH region, establishing this as a major site of Top3α-mediated mtDNA 
separation. 
 
To provide further support for the location of the observed catenane junction, we 
cleaved mtDNA isolated from cells depleted of Top3α and Top1mt using BamHI 
(which cleaves mtDNA at position 14,258) in combination with a series of other 
restriction enzymes to produce DNA fragments either excluding or including OriH. 
The probe was placed outside of the NCR, on the basis that catenated species would 
only be observed when the restriction digest extends beyond the catenane junction.  
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High levels of the slow-migrating species were limited to the region including OriH 
and immediately upstream (Fig. 5F, G), suggesting that this is the primary site of 
post-replicative mtDNA separation. 
 
Pathogenic TOP3A variants are associated with mtDNA instability causing 
human pathology 
In parallel to the molecular characterisation of Top3α activity, we additionally 
identified an individual with adult-onset mitochondrial disease characterised by a 
complex PEO syndrome with prominence of cerebellar features - including upper and 
lower limb ataxia - and dysarthria (Fig, S6A-D). A detailed summary of the clinical 
presentation is provided in the Methods. To determine the precise genetic aetiology, 
whole exome sequencing was undertaken with informed consent. The mean depth per 
consensus coding sequence was 52-fold, with 78.69 % bases at 20-fold coverage (Fig. 
S6F). Analysis of autosomal recessive variants in nuclear genes encoding proteins 
involved in DNA transcription, replication and maintenance (Fig. S6G) revealed two 
heterozygous variants in TOP3A (GenBank: NM_004618.3); a c.298A>G 
(p.Met100Val) missense change and a c.403C>T (p.Arg135*) nonsense change (Fig. 
6A). In the Exome Aggregation Consortium (ExAC) database, the p.Met100Val 
missense variant was present in 7/120600 alleles (MAF = 5.804x10-5) and p.Arg135* 
variant was present in 24/121054 alleles (MAF = 1.983 × 10-4), all in the 
heterozygous state. Both variants occurred in the topoisomerase/primase (Toprim) 
domain, which contributes to substrate binding and metal ion coordination (Aravind 
et al., 1998). The variants were confirmed in the patient by Sanger sequencing, while 
her unaffected mother and daughter were shown to be heterozygous carriers of the 
p.Arg135* nonsense change.  
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A diagnostic skeletal muscle biopsy revealed abundant COX-deficient and ragged-red 
fibres, pathological hallmarks of mtDNA-related disease (Fig. S6E). Real-time PCR 
analysis of mtDNA from individual muscle fibres showed the presence of clonally-
expanded mtDNA deletions at very high levels (>80 % mutated mtDNA) in the 
majority of COX-deficient - but not COX-positive - fibres (Fig. 6B). Patient muscle 
mtDNA was further subjected to deep sequencing and mapping of breakpoints, which 
revealed extensive, variable mtDNA rearrangements (Fig. 6C), while no 
rearrangements were found in an unaffected control using the same methodology. 
Most rearrangements of patient mtDNA were predicted deletions within the major 
arc, with a cluster of breakpoints at the 3' end of the D-loop, a recognised hotspot for 
mtDNA deletions (Zeviani et al., 1989).  
 
We then assessed the degree of mtDNA catenation in patient fibroblasts carrying the 
Top3α M100V variant by electron microscopy. Interestingly, while mtDNA isolated 
from control human fibroblasts (Fig. S7) was equally distributed between free and 
catenated states (45 % free and 55 % catenated), in the patient the degree of mtDNA 
catenation was drastically increased (Fig.6D-G). In these cells up to 70 % of the 
mtDNA was assembled in complex structures  with only 30 % in monomeric form 
(Fig. 6H). Taken together, these features support the direct involvement of Top3α in 
mitochondrial DNA maintenance and segregation, since its deficiency severely affects 
the topology and stability of human mtDNA in vivo. 
 
To directly assess the impact of the M100V missense variant upon the enzymatic 
activity of Top3α, we purified recombinant Top3α from Sf9 insect cells. In addition 
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to the wild-type and M100V variants, we also purified a Y362F mutant, which 
represents mutation of the catalytic tyrosine residue responsible for covalent linkage 
to the DNA substrate (Hanai et al., 1996). This variant is capable of binding, but not 
cleaving, ssDNA substrates (Goulaouic et al., 1999). The p.Arg135* variant lacks the 
C-terminal 867 amino acids, including the catalytic tyrosine residue, and was not 
analysed further. The enzyme preparations were judged to be of high purity by 
staining of SDS-PAGE gels (Fig. 7A). Gel-shift analysis of DNA binding activity 
confirmed that all three protein variants were capable of binding ssDNA, and did not 
show any apparent differences between the binding activities (Fig. 7B). We next 
assessed the effect of the M100V variant upon Top3α-mediated DNA relaxation. 
When incubated with negatively supercoiled dsDNA substrates, wild-type Top3α 
produces distinct topological isomers, which can be visualised on ethidium bromide-
free agarose gels. The addition of ethidium bromide to the gels allows nicked dsDNA 
to be separated from fully-relaxed substrate. Under these conditions the M100V 
variant was substantially less efficient than the wild-type enzyme at fully relaxing a 
plasmid substrate (Fig. 7C). The M100V variant also produced less nicked template 
compared to the wild-type protein, which has been associated with the open, 
decatenating form of the enzyme (Cejka et al., 2012), and the observed impaired 
catalytic activity provides a molecular basis for the observed cellular phenotypes. 
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DISCUSSION 
 
At the completion of mtDNA replication, nucleoids must not only be physically 
separated but also distributed throughout the mitochondrial network. The 
colocalisation of the mitochondrial genome with its protein products of the oxidative 
phosphorylation (OXPHOS) system at the inner mitochondrial membrane means that 
proper mtDNA distribution is crucial to maintain proper cellular energy homeostasis. 
In this work we demonstrate that Top3α is required for mtDNA separation in vivo. 
Top3α has been characterised as an ssDNA decatenase (Yang et al., 2010), but is also 
capable of resolving hemicatenanes, which are structures in which only one strand of 
a double-stranded DNA molecule is interlinked with one strand of another double-
stranded DNA molecule. These types of structures can form as a final intermediate 
from the unwinding of converging replication forks, and E. coli topoisomerase III 
(together with the RecQ helicase) is capable of resolving late-replicating plasmid 
intermediates in vitro (Suski and Marians, 2008). The notion that the mtDNA 
catenanes produced by loss of Top3α represent hemicatenanes, rather than fully 
catenated molecules, is supported by the observation that the mtDNA molecules 
remain interlinked following restriction digestion, but can be resolved to near full-
length, linear mtDNA molecules by a single-stranded DNA-specific nuclease (Fig. 
3E). Resolution of fully-replicated mtDNA molecules through a hemicatenane 
intermediate would presumably obviate the requirement for a type II topoisomerase 
activity in mitochondria, and in agreement with this notion we were unable to detect 
either type II topoisomerase in our mitochondrial preparations. The function of 
Top3α may be evolutionarily conserved, in as much as Drosophila mutants 
specifically lacking the mitochondrial isoform of Top3α show loss of mtDNA copy 
 19 
number and an increased rate of mtDNA deletions (Tsai et al., 2016; Wu et al., 2010), 
even if the molecular basis for this effect in flies remains unknown. 
 
The role of nuclear Top3α in the dissolution of double Holliday junctions during 
homologous recombination requires the RecQ-family helicase BLM, as well as the 
OB-fold proteins RMI1 and RMI2 (the BTR complex). However, whereas the loss of 
Top3α was found to affect mtDNA maintenance, topology and separation, 
knockdown of the other BTR complex components (BLM, RMI1, or RMI2) had no 
discernable effect, and no mitochondrial isoforms of these proteins were detectable 
(Fig. 2). These data demonstrate that mitochondrial Top3α functions independently of 
its nuclear cofactors. Since mitochondria are not known to possess a machinery for 
homologous recombination, it could be expected that the physiological substrates of 
Top3α in mitochondria differ from those in the nucleus. It is possible that 
mitochondrial Top3α is capable of performing its role independently of other 
cofactors or, alternatively, that a separate set of cofactors exists that helps Top3α to 
fulfil its mitochondrial function. 
 
We have mapped the location of the junction between non-separated daughter 
mtDNA molecules to a region near OriH. Our data suggest that replication has been 
completed, but that the newly replicated mtDNA molecules remains interlocked at 
this site. Available models of mtDNA replication stipulate that replication initiates in 
the region of OriH and is essentially unidirectional, and so this region would logically 
also be the site of leading strand replication completion. However, as lagging strand 
replication initiates at a separate site, the steps that lead to the completion of lagging 
strand replication, and to the formation of the resolution structure, remain unclear.  
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mtDNA is anchored to the mitochondrial inner membrane, with the OriH region being 
the probable attachment site (Albring et al., 1977). It therefore seems plausible that 
the unlinking of replicated mtDNA molecules at the origin of replication would be 
coupled to the separation of nucleoids through mitochondrial dynamics. 
Mitochondrial division sites coincide with regions in which contacts are formed 
between mitochondria and the endoplasmatic reticulum (ER). These contact sites are 
in turn spatially linked to nucleoids involved in active mtDNA synthesis, a process 
that occurs before mitochondrial division (Lewis et al., 2016). The data suggest that 
contacts between the ER and mitochondria may help to coordinate licensing of 
mtDNA synthesis with division to distribute newly replicated nucleoids to daughter 
mitochondria. This process could be disrupted by either a failure of mtDNA 
separation (leading to mtDNA catenation) or a failure of mitochondrial fission 
(leading to nucleoid clustering). In support of this notion, loss of the fission GTPase 
DRP1 in mice causes severe mtDNA nucleoid clustering and a mosaic deficiency of 
mitochondrial respiration (Ishihara et al., 2015). Defects in the mitochondrial fusion 
machinery are also associated with mtDNA instability and OXPHOS deficiency in 
both animal models (Chen et al., 2010) and in human pathology (Amati-Bonneau et 
al., 2008; Hudson et al., 2008; Rouzier et al., 2012). For instance, a proteolytic 
fragment of the OPA1 protein has been implicated in anchoring of mtDNA to the 
membrane, with loss of this fragment leading to nucleoid clustering (Elachouri et al., 
2011). Pathogenic variants in the OPA1 gene cause changes in the distribution of 
mtDNA molecules, with some regions within the mitochondrial network being devoid 
of mtDNA and other regions containing larger nucleoid assemblies. Pathological 
sequence variants in RNASEHI have also been associated with defective mtDNA 
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segregation (Akman et al., 2016); in both examples, these are associated with adult-
onset PEO+ phenotypes (Amati-Bonneau et al., 2008; Hudson et al., 2008; Reyes et 
al., 2015). In this respect, the identification of pathogenic TOP3A variants in a patient 
with the clinicopathological hallmarks of a disturbance in mtDNA maintenance is 
significant, and as such pathogenic variants in this gene should be considered in 
patients with PEO and multiple mtDNA deletions in muscle, but without a firm 
genetic diagnosis.  
 
It appears that mitochondrial dynamics and mtDNA replication are closely linked 
processes, and in this context Top3α may function to coordinate the separation of 
newly replicated mtDNA daughter molecules with mitochondrial fission. Similarly to 
the separation of sister chromatids in the nucleus during mitosis, mitochondrial fission 
may apply a physical separating force upon newly replicated mtDNA molecules, 
which could stimulate Top3α-dependent separation. In future studies we hope to 
further address these and related ideas to clarify the molecular machinery underlying 
proper mtDNA separation and segregation in mammalian cells.  
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FIGURE LEGENDS 
 
Figure 1: Loss of Top3α  affects mtDNA maintenance 
(A) Mitochondrial localisation of topoisomerases by western blotting of isolated cell 
fractions. HeLa cells were fractionated into nuclei/unbroken cells, cytosol, whole 
mitochondria, and mitoplasts. Mitochondria and mitoplast fractions were additionally 
treated with proteinase K to remove externally bound proteins. Marker proteins used 
were histone H3 (nucleus), TFAM (mitochondrial matrix) and apoptosis-inducing 
factor (AIF; intermembrane space). (B) Efficiency of depletion of Top3α, Top2α and 
Top2β assessed by western blotting of HeLa cell lysates. β-actin is used as a loading 
control. (C) Efficiency of depletion of Top1mt assessed by western blotting of 
mitochondrial lysate of HeLa cells. Voltage-dependent anion channel (VDAC) is used 
as a loading control. (D) Southern blot analysis of mtDNA copy number and 7S DNA 
levels following siRNA depletion of topoisomerases as in (B). mtDNA was linearised 
using BamHI and detected using probe (a). 28S rDNA is used as a loading control. 
(E) Quantification of mean mtDNA copy number and 7S DNA levels following 
siRNA depletion of topoisomerases (n=3). (F) mtDNA topology following siRNA 
depletion of topoisomerases as in (B). Uncut DNA (3 µg) was separated on low-
percentage agarose, blotted and detected using probe (a). BamHI-treated DNA marks 
the migration of linear mtDNA and E. coli TopoI-treated DNA marks the migration of 
relaxed, open circular form mtDNA. 
 
Figure 2: Mitochondrial Top3α  is independent of the BTR complex 
(A) Mitochondrial localisation of protein components of the BTR complex by western 
blotting of cell fractions as in Fig. 1A. Top3α blot is reproduced from Fig. 1A for 
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reference. (B) Efficiency of depletion of BTR complex components assessed by 
western blotting of HeLa cell lysates. β-actin is used as a loading control. (C) 
Southern blot analysis of mtDNA copy number and 7S DNA levels following siRNA 
depletion of BLM, RMI1 and RMI2 as in (B). 28S rDNA is used as a loading control. 
(D) mtDNA topology following siRNA depletion of BTR complex proteins. Uncut 
DNA (3 µg) was separated on low-percentage agarose, blotted and detected using 
probe (a). BamHI-treated DNA marks the migration of linear mtDNA and E. coli 
TopoI-treated DNA marks the migration of relaxed, open circular form mtDNA. 
 
Figure 3: Loss of Top3α  induces mtDNA catenane formation  
(A+B) Representive EM images of monomeric, open circular form mtDNA (A) and 
monomeric, supercoiled mtDNA (B) from control siRNA-treated cells. Scale bars, 
200 nm. (C+D) Representative EM images of catenated mtDNA from Top3α 
depleted cells. Scale bars, 0.5 µm. (E) Enzymatic resolution of high molecular weight 
mtDNA species from Top3α depleted cells. Uncut total DNA samples (3 µg) were 
separated on low-percentage agarose gels and detected using probe (a). BamHI-
treated DNA marks the migration of linear mtDNA and E. coli TopoI-treated DNA 
marks the migration of relaxed, monomeric mtDNA. DNA was treated with E. coli 
TopoI, S1 nuclease or T7 endonuclease I prior to separation. (F) Representative EM 
images of catenated mtDNA from Top3α/Top1mt depleted cells. Scale bar, 0.5 µm. 
(G+H) Representative EM images of late-replicating mtDNA molecules from cells 
depleted of both Top3α and Top1mt. Scale bars, 200 nm. (I) Quantification of 
mtDNA molecules found in monomeric (relaxed and supercoiled) or catenated 
topological forms from EM analysis following the indicated siRNA treatments. Data 
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are expressed as a percentage representing mean values from three independent 
experiments made in duplicate for each study group.  
 
Figure 4: Loss of Top3α  perturbs nucleoid separation and distribution within 
the mitochondrial network 
(A) Representative confocal microscopy images of HeLa cells following the indicated 
siRNA treatments, showing merged channels of DNA and TOM20 (upper panels) and 
single channels of DNA (lower panels). Scale bar, 10 µm. (B) Magnifications of the 
yellow boxed areas in (A) showing the imaged nucleoids in confocal (gray, left) and 
g-STED (Green Fire LUT, right). Scale bar, 600 nm. (C) Quantification of nucleoid 
number per cell following the indicated siRNA treatments. Nucleoid number is 
expressed as a percentage of control siRNA treated cells (from 4 independent 
experiments, n≥9 cells analyzed). (D) Mean size of nucleoids determined by g-STED 
under the indicated siRNA conditions. Number of nucleoids analyzed from 
independent experiments: control siRNA = 244; Top3α siRNA = 357; Top3α + 
Top1mt siRNA = 361; RMI1 siRNA = 393).  
 
Figure 5: Catenane formation is centred around OriH 
(A) Restriction map of human mtDNA indicating sites of restriction enzymes used. 
Black bar indicates the probe. (B) Total DNA from cells treated with control siRNA, 
Top3α siRNA or Top1mt siRNA was restricted with the indicated enzymes, separated 
on agarose and blotted. Additional species present in Top3α depleted cells are 
indicated with arrows. (C) Total DNA from cells simultaneously depleted of both 
Top3α and Top1mt was restricted and blotted as in (B). Where indicated, samples 
were treated with S1 nuclease immediately before separation on gel. (D+E) 
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Representative electron micrographs of X-shaped, NCR-containing mtDNA 
molecules, with interpretations. Restriction enzyme digestion with PvuII/XhoI (D) or 
BamHI/ClaI (E) generates species with arm lengths that map the junction to the OriH 
region: 1.8kb/2.5kb for PvuII/XhoI and 1kb/2.5kb for BamHI/ClaI. Scale bars, 200 
nm. (F) Total DNA from cells depleted of Top3α and Top1mt was restricted with the 
indicated enzymes, separated on agarose and blotted using probe (b). X-shaped 
molecules are only visible when the probed fragment includes the molecule junction. 
(G) Quantification of the proportion of X-shaped species, normalised to the level of 
linear species for the same digestion. Black bar indicates the probe. Dotted lines 
indicate the sites of restriction enzymes used. Gene loci and key sequence elements 
are indicated above the graph. 
 
Figure 6: Pathological Top3α  variants are associated with mtDNA instability 
(A) Domain architecture of Top3α, indicating the sites of the identified compound 
heterozygous variants. MTS indicates the mitochondrial targeting sequence, and 
roman numerals indicate conserved domains. (B) Quantitative single-fibre real-time 
PCR reveals that the majority – but not all - of the COX-deficient fibres exhibit high 
levels of a clonally-expanded mtDNA deletion involving the MTND4 gene, a 
signature of multiple mtDNA deletions. Data represent median values +/- SEM. (C) 
DNA rearrangements in Top3α patient. Lines represent predicted mtDNA deleted 
(blue) or duplicated (red) regions. (D-G) Representative EM images of mtDNA from 
patient fibroblasts alongside interpretation are shown. (D) Monomeric open circle 
(1n). (E) Supercoiled monomeric mtDNA (1nsc). (F) Catenane consisting of dimeric 
circles. (G) Complex catenane consisting of trimeric circles. All scale bars, 200 nm. 
(H) EM topological quantification of mtDNA in monomeric (open circle and 
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supercoiled) and catenated forms from control and patient fibroblasts. Data represent 
the mean of two independent experiments made in duplicate for each study group. 
 
Figure 7: The M100V variant of Top3α  shows impaired catalytic activity 
(A) Purified Top3α variants used for biochemical characterisation. 8 pmol of each 
protein was separated and detected on Mini-PROTEAN TGX Stain-Free gels (Bio-
Rad). (B) EMSA to assess binding of Top3α variants to a 5' radiolabelled 80-nt 
ssDNA oligonucleotide. 10 fmol ssDNA was incubated with increasing amounts of 
Top3α (0, 107.5, 215, 430 and 860 fmol) for 15 min at 37 °C, then separated by 8 % 
PAGE. (C) DNA relaxation assay. 200 ng negatively supercoiled pBluescript II 
SK(+) plasmid DNA was incubated with increasing amounts of Top3α protein (1.75, 
5 and 10 pmol) for 45 min at 37 °C, then separated on 1 % agarose and imaged under 
UV light. Nt.BspQI (a nicking endonuclease) treatment represents the migration of 
nicked (open circle) DNA and E. coli TopoI treatment represents the migration of 
relaxed, covalently closed DNA. (D) Model for the mechanism of action of Top3α in 
human mitochondria. Following mtDNA replication, Top3α is required to resolve 
mtDNA hemicatenanes and separate the newly-synthesised mtDNAs. Loss of 
mitochondrial Top3α activity leads to mtDNA catenation and impaired nucleoid 
segregation.   
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STAR METHODS 
 
CONTACT FOR REAGENT AND RESOURCE SHARING 
 
Further information and requests for resources and reagents should be directed to and 
will be fulfilled by the Lead Contact, Claes Gustafsson 
(claes.gustafsson@medkem.gu.se). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Case Report 
A 67-year-old-woman presented with slowly progressive ptosis, intermittent double 
vision, mild dysphagia and nasal regurgitation, sensorineural hearing loss, rapid 
cycling mood disorder, cardiac arrhythmias (necessitating a permanent pace maker 
insertion), reduced exercise tolerance and prominent cerebellar ataxia. Her sister died 
aged 27 years from complications of systemic lupus erythematosus. Her father was 
deceased but no history of myopathy and her mother, aged 93 years and five children 
were otherwise well. Examination revealed bilateral ptosis, moderate to severe 
asymmetric PEO, frontalis muscle over activity, staccato speech, neck flexor 
weakness (MRC4+/5), proximal limb weakness (MRC4+/5), upper limb dysmetria, 
retained tendon reflexes and a broad-based gait. Pyramidal or extrapyramidal features 
were not found. Serum lactate was 1.3mmol/L (<2) and serum creatine kinase was 
251 U/L (10-160). Nerve conduction studies showed a mild sensory neuropathy and 
brain MRI (Magnetic Resonance Imaging) revealed bilateral symmetrical changes 
within the thalami, red nuclei and long tracts within the midbrain, in addition to 
 34 
cerebellar atrophy. Cardiology work up including an echocardiogram revealed 
initially impaired left ventricular (LV) function (LVEF 55-60 %) and right ventricular 
outflow tract ectopic beats with symptoms necessitating computerized assisted 
balloon mapping of right ventricular outflow tract ectopy and ablation. Holter 
electrocardiogram (ECG) showed non-sustained atrial and ventricular tachycardia 
necessitating placement of a permanent pace maker. 
 
Cell lines 
HeLa cells were grown at 37 °C, 5 % CO2 in Dulbecco's Modified Eagle Medium 
(DMEM; 4.5 g/l glucose, 2 mM glutamine, 110 mg/ml sodium pyruvate) 
supplemented with 10 % foetal bovine serum (FBS) and 5 % penicillin/streptomycin. 
Fibroblasts were grown as above with the addition of 50 µg/ml uridine. Untransfected 
(parental) Flp-In T-REx 293 cells were grown in DMEM supplemented with 10 % 
FBS, 5 % penicillin/streptomycin, 15 µg/ml blasticidin, and 100 µg/ml Zeocin. 
Following stable transfection, these cells were grown as above with the addition of 50 
µg/ml hygromycin and without Zeocin. Spodoptera frugiperda (Sf9) cells used for 
recombinant protein expression were grown in suspension in HyClone SFX-Insect 
medium supplemented with 5 % FBS and 5 % penicillin/streptomycin at 27 °C. 
 
METHOD DETAILS 
 
Cell line manipulation 
For siRNA transfections, HeLa cells were reverse transfected with 5 nM of siRNA 
using Lipofectamine RNAiMAX. After three days cells were re-transfected, for a total 
of six days of transfection. For siRNA transfections of Flp-In T-REx 293, cells were 
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plated 24 hr before transfection and forward transfected using the same concentrations 
and conditions as for HeLa cells. 
 
Cell fractionation 
Suspension HeLa cells (approx. 5 × 108) were pelleted by centrifugation at 300 × g 
for 10 min, washed in PBS and weighed to determine the volume (assuming a cell 
density of 1.25 g/ml). Pellet was resuspended in 9 volumes hypotonic buffer (20 mM 
HEPES pH 8.0, 5 mM KCl, 1.5 mM MgCl2, 2 mM DTT, 1 mg/ml BSA, 1 mM PMSF 
and 1 × proteinase inhibitors (1 mM PMSF, 2 mM pepstatin A, 0.6 mM leupeptin and 
2 mM benzamidine in 100 % ethanol)), incubated on ice for 10 minutes then 
homogenised using 10 strokes of a 15 ml glass Dounce homogeniser with tight-fitting 
pestle. A two-thirds volume of 2.5 × MSH buffer (525 mM mannitol, 175 mM 
sucrose, 20 mM HEPES (pH 8.0), 5 mM EDTA, 1 mg/ml BSA, 0.2 mM PMSF, 2 
mM DTT, and 1 × protein inhibitors) was then added and the homogenate was 
centrifuged twice at 1600 × g for 10 min to pellet nuclei and unbroken cells. The 
supernatant was collected and centrifuged at 10,000 × g for 10 min, and the 
supernatant from this step was retained at the cytosolic fraction. The pellet was then 
resuspended in 1 × MSH (210 mM mannitol, 70 mM sucrose, 20 mM HEPES (pH 
8.0), 2 mM EDTA, 1 mg/ml BSA, 0.2 mM PMSF and 1 × proteinase inhibitors), 
supplemented with 10 mM MgCl2, to a final concentration of 2 mg/ml (assuming 10 
mg of mitochondria per gram of cells). 125 U of benzonase was added and incubated 
for 30 min on a roller at 4 °C. Samples were pelleted at 10,000 × g for 10 min and 
washed twice with 5 ml of 1 × MSH without BSA. Pellets were resuspended in a 
minimal volume of 1 × MSH and loaded onto a two-step sucrose gradient (1.5 M/1 M 
sucrose made up in gradient buffer (10 mM HEPES pH 7.8, 5 mM EDTA, 2 mM 
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DTT)) and centrifuged at 130,000 × g (39,000 rpm in a Beckman Coulter TLS55 
rotor) for 1 hour at 4 °C. The interface fraction was collected and four volumes 
gradient buffer added, then pelleted at 10,000 × g for 10 min. This stage represents 
the mitochondrial fraction. This pellet was divided into two, and half used for making 
mitoplasts according to the 'swell-contract' method (Pallotti and Lenaz, 2007). 
Mitochondria were resuspended in potassium phosphate buffer (pH 7.2) and 
incubated on ice for 20 min. ATP and MgCl2 were then added to final concentration 
of 1 mM each, incubated on ice for a further 5 min, then pelleted by centrifugation at 
15,000 × g for 10 min and washed once with 1 × MSH. Half of each of the 
mitochondrial and mitoplast fractions were treated with proteinase K to remove 
externally-bound proteins. Fractions were incubated with 50 µg/ml proteinase K for 
30 min at 4 °C, then the reaction was stopped by the addition of 5 mM PMSF and 
centrifuged at 15,000 × g for 10 min, and the pellets washed once with 1 × MSH. 
 
DNA preparation 
For extraction of total cellular DNA, cells were washed once with PBS before being 
solubilised in cell lysis buffer (75 mM NaCl, 50 mM EDTA, 20 mM HEPES (pH 
7.8), 0.5 % SDS, 0.2 mg/ml proteinase K) and added to an equal volume of phenol. 
DNA was purified by two consecutive rounds of sequential extraction with phenol 
and chloroform, followed by isopropanol precipitation and resuspension in TE pH 
8.0. For preparation of mtDNA for EM analysis, mitochondria were first isolated from 
1 × 107 cells using a MACS mitochondria isolation kit (Miltenyi Biotec) according to 
manufacturer's instructions. Cells were lysed by 15 passages through a 27 gauge 
needle fitted to a 1 ml syringe, and nuclei were removed by centrifugation at 300 × g 
for 10 min at 4 °C. The supernatant from this step was applied to the column through 
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a 20 µm pre-separation filter. Isolated mitochondria were lysed by the addition of 0.5 
% SDS and 0.5 mg/ml proteinase K at 55 °C for 2 hr. DNA was then extracted by 
phenol/chloroform extraction and ethanol precipitation, and pellets were resuspended 
in TE pH 8.0. 
 
DNA modifying enzyme treatments and Southern blotting 
DNA (3 µg) was digested using 10 U of the indicated restriction enzymes (all from 
New England Biolabs) according to the manufacturer's instructions. For restriction 
mapping experiments (Figs 5 and S5), 500 ng/ml ethidium bromide was included in 
the reactions to inhibit thermal branch migration. Where indicated, samples were 
treated with DNA modifying enzymes immediately prior to loading on the gel, 
according to manufacturer's instructions. Enzymatic treatments were all carried out 
for 30 min at 37 °C, and used 5 U E. coli Topoisomerase I, 25 U S1 nuclease, 5 U T7 
endonuclease I, 5 U human Topoisomerase IIα or Topoisomerase IIβ, 2.5 U E. coli 
gyrase or 5 U E. coli TopoIV. For restricted samples, DNA was separated on 0.6 % 
agarose gels containing 500 ng/ml ethidium bromide at 100 V for 4 hr. Uncut DNA 
samples were separated on 0.4 % agarose without ethidium bromide, at 35 V for 22 
hr. After electrophoresis, DNA gels were depurinated by incubation in 0.25 M HCl 
for 20 min, then incubated in denaturation buffer (0.5 M NaOH, 1.5 M NaCl) twice 
for 10 min, and neutralisation buffer (0.5 M tris-HCl (pH 7.4), 1.5 M NaCl) twice for 
10 min. DNA was blotted onto a charged nylon membrane overnight, then cross-
linked by exposure to 254 nm UV, 200 mJ/cm2. Radiolabelled dsDNA probes were 
made by random labelling of gel-extracted PCR products using a Prime-It II kit 
(Agilent). For probe primer sequences see Table S1.  
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Immunoblotting 
Whole cell lysates were prepared by incubation in cell lysis buffer (50 mM Tris-HCl 
(pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 % (w/v) Triton X-100, 1 × proteinase 
inhibitors) for 30 min at 4 °C, followed by centrifugation at 11,000 × g for 3 min and 
retaining the supernatant. Protein samples were separated by SDS-PAGE on gradient 
(4 % - 20 %) polyacrylamide gels, blotted onto nitrocellulose membranes and probed 
with the indicated antibodies. 
 
EM analysis of mtDNA 
After purification as described above, mtDNA was prepared for EM as described in 
(Thresher and Griffith, 1992). In brief, mtDNA was suspended in a solution of 0.25 M 
ammonium acetate pH 7.5 and cytochrome C (7 µg/ml). A 50 µl drop was placed on a 
sheet of parafilm for 3-10 minutes to allow the DNA to become trapped in the 
denatured protein film. The film was picked up with a parlodion covered EM grid, 
dehydrated, air dried, and shadow cast with 80 % platinum: 20 % palladium in a high 
vacuum. At least 100 images for each study group were captured using a Gatan Orius 
real time CCD camera (Pleasanton, CA, USA) attached to an FEI Tecnai T12 
TEM/STEM instrument (Hillsboro, OR, USA) operated at 40 kV. EM analysis was 
made using Gatan Digital Micrograph software. For publication the contrast was 
inverted and grey scale levels optimized using Adobe Photoshop.  
 
EM analyses of single stranded mtDNA 
mtDNA isolated under different experimental conditions was incubated with E. coli 
SSB protein (Amersham Biochemicals), at a ratio of 3 micrograms of SSB per 
microgram of mtDNA, in 10 mM HEPES pH 7.6, 4 mM MgCl2, and 50 mM NaCl for 
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20 min at room temperature (RT). After incubation the complexes were fixed with 0.6 
% glutaraldehyde for 5 min at RT and chromatographed through 2 ml columns of 6 % 
agarose beads (Agarose Bead Technologies, Madrid, Spain) equilibrated in 10 mM 
Tris HCl pH 7.6 and 0.1 mM EDTA. The samples were adsorbed to thin carbon 
supports in the presence of 2 mM spermidine, washed and rotary shadow-cast with 
tungsten. Imaging was done as above.  
 
Immunocytochemistry 
Cells previously seeded on coverslips were fixed in 4 % PFA in PBS for 10 min at 
RT, and subsequently permeabilized with 0.1 % Triton X-100 in PBS for 5 min at RT. 
After blocking of unspecific sites, cells were incubated overnight at 4 °C with the 
indicated primary antibodies, prepared in 3 % BSA in PBS. Cells were then incubated 
with the corresponding secondary antibodies in 3 % BSA in PBS for 2 hr at RT. 
Finally, coverslips were extensively washed with PBS, prior to mounting with 
Aqua/Poly-mount (Polyscience Inc.). 
 
Confocal and g-STED microscopy 
Imaging was performed by using a Leica TCS SP8 g-STED microscope, equipped 
with a white light laser and a 100 × objective lens (HC PL APO CS2 100 × oil, 1.40 
NA). For confocal images of TOM20 and DNA, Z-stacks in accordance with the 
Nyquist sampling criteria were taken by exciting the fluorophores at 647 nm and 594 
nm respectively, and signal was collected by Hybrid detectors. Stimulated emission 
depletion was performed with a 775 nm depletion laser. 2D confocal and g-STED 
images were acquired sequentially with the optical zoom set to obtain a voxel size of 
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22.7 × 22.7 nm. Excitation was provided at 594 nm and signal was collected by 
Hybrid detectors. Gating between 0.3-6 ns was applied. 
 
Histopathology, Biochemical and Genetic Studies 
Diagnostic skin and muscle biopsies were performed according to standard protocols. 
Skeletal muscle biopsy was subject to routine diagnostic histopathological protocols 
including hematoxylin and eosin staining, as well as COX, SDH and sequential COX-
SDH histochemistry. Whole mitochondrial genome sequencing was undertaken using 
muscle DNA. The presence of mitochondrial DNA rearrangements was investigated 
using an established, diagnostic real time PCR assay (He et al., 2002). Candidate 
screening of all exons and intronic regions of nuclear genes frequently associated with 
PEO and multiple mtDNA deletions (POLG1, NM_002693; RRM2B, NM_015713; 
SLC25A4, NM_001151; TWNK, NM_021830; POLG2, NM_007215.3; TK2, 
NM_004614.4; RNASEH1, NM_002936) was performed, but no pathogenic variants 
were identified. 
 
Whole Exome Sequencing, Analysis and Interpretation 
Exome capture was attained using the Agilent Sure Select Human All Exon V5 
(50Mb) capture kit, sequenced using the Illumina GAIIx platform in 75 base pair 
reads and aligned to the human reference genome (UCSC hg19). Called variants were 
restricted to exonic (coding) or splice-site variants with a minor allele frequency 
(MAF) less than or equal to 0.01 (1 %) from 378 in-house controls and external 
variant databases (ExAC, NHLBI ESP, 1000 Genomes). Autosomal dominant 
(heterozygous) and autosomal recessive (homozygous and compound heterozygous) 
inheritance were equally considered. Any rare variants in nuclear genes associated 
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with mtDNA maintenance disorders were first examined. Next, variants were filtered 
using Gene Ontology (GO)-Terms to prioritise nuclear genes encoding proteins 
involved in mitochondrial function, DNA repair or replication. GO-Terms employed 
were the wildcard term ‘mitochondr*’, ‘DNA repair’, ‘replication’, ‘transcription’, 
‘nucleotide’, ‘purine’, ‘pyrimidine’, ‘exonuclease’, ‘polymerase’, ‘topoisomerase’, 
‘ligase’, ‘helicase’ and ‘nucleoside’. Copy number variants (CNVs) were also 
examined using the same GO-Terms. Identified heterozygous TOP3A 
(NM_004618.3) variants were confirmed by Sanger sequencing using forward and 
reverse primers flanked with universal M13-derived tags, according to standard 
protocols. Primers for Sanger sequencing are provided in Table S1. 
 
Protein purification 
The human Top3α sequence (or the Y362F or M100V variants), lacking the N-
terminal 15 amino acids and with the additional of a C-terminal 6 × His tag, were 
cloned into the vector pBacPAK9 (Clontech) and used to prepare recombinant 
Autographa californica nuclear polyhedrosis virus stocks according to the 
manufacturer's instructions. These viruses were used to infect Sf9 insect cells. Whole 
cell extracts were prepared by resuspending cell pellets in a lysis buffer of 20 mM 
Tris-HCl pH 8.0, 500 mM NaCl, 10 mM β-mercaptoethanol and 1 × proteinase 
inhibitors, and freeze-thawing in liquid nitrogen. The extract was cleared by 
centrifugation at 20,000 rpm for 30 min at 4 °C using a Sorvall Surespin 630 
rotor.  The supernatant was loaded onto 2 ml of His-Select Nickel affinity gel (Sigma) 
equilibrated with buffer A (20 mM Tris-HCl pH 8.0, 400 mM NaCl, 10 % glycerol, 
10 mM β-mercaptoethanol and 1 × proteinase inhibitors) containing 10 mM 
imidazole, washed with buffer A (20 mM imidazole) and finally eluted with buffer A 
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(250 mM imidazole). The eluate was further purified over a Superdex 200 16/600 
(GE Healthcare Life Sciences) equilibrated with buffer B (20 mM Hepes pH 7.2, 10 
% glycerol, 1 mM dithiothreitol and 1 × proteinase inhibitors) containing 400 mM 
NaCl. The peak fractions were diluted 1:1 with buffer B (0 M NaCl) before being 
loaded onto HiTrap SP HP (GE Healthcare Life Sciences) equilibrated in buffer B 
(0.2 M NaCl). The column was eluted with a linear gradient (10 ml) of buffer B 
(0.2−1.2 M NaCl). The peak fractions were diluted 1:4 with buffer B (0 M NaCl) and 
finally loaded onto HiTrap Heparin HP (GE Healthcare Life Sciences) also 
equilibrated in buffer B (0.2 M NaCl). The column was eluted with a linear gradient 
(10 ml) of buffer B (0.2−1.2 M NaCl). Recombinant Top3α proteins eluted at 
approximately 700 mM NaCl. 
  
Electrophoretic mobility shift assay (EMSA) 
Reactions (20 µl) contained 10 fmol ssDNA substrate (80 nt, labelled at the 5′-end 
with [γ-32P] ATP), 25 mM HEPES pH 7.5, 1 mM DTT, 100 µg/ml BSA, 10 % 
glycerol, 70 mM NaCl and indicated amounts (0, 107.5, 215, 430 or 860 fmol) of the 
different Top3α variants. Reactions were incubated at 37 °C for 15 min, then 
transferred to ice. Samples were separated on 8 % PAGE-TBE gels at 150 V for 50 
min in 0.5 × TBE running buffer at 4 °C. Oligo sequence is provided in Table S1. 
  
DNA relaxation assay 
Top3α recombinant proteins were dialysed into a 1 × reaction buffer of 25 mM Tris-
HCl pH 7.4, 5 mM MgCl2, 50 mM NaCl and 1 mM DTT, then BSA was added to 100 
µg/ml. Reactions (30 µl) contained increasing amounts (1.75, 5 or 10 pmol) of Top3α 
in 1 × reaction buffer with 200 ng of freshly-prepared supercoiled pBluescript II 
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SK(+) substrate. The reactions were incubated at 37 °C for 45 min and then treated 
with 1 µl of proteinase K (20 mg/ml), 2 µl of 5 % SDS and 2 µl of 50 mM EDTA at 
37 °C for 30 min before 6 µl of 6X Orange DNA loading Dye (Thermo Scientific) 
was added. Reactions were separated on 1 % agarose TAE gels with or without 500 
ng/ml ethidium bromide at 100 V for 4 hr. Gels run without ethidium bromide were 
subsequently stained with 500 ng/ml ethidium bromide in water for 30 min before 
being imaged under UV light. 
 
Mapping of mtDNA rearrangements using deep sequencing 
Total DNA from muscle (from the TOP3A patient and an unaffected control) was 
extracted and subjected to deep sequencing on a NextSeq 500 using the Nextera DNA 
library preparation kit (Illumina). A total of 57792541 and 58045634 reads were 
obtained for the TOP3A patient and wild type samples, respectively. An initial 
alignment to chrM (rCRS assembly) and nuclear chromosomes was performed using 
bowtie2 (Langmead and Salzberg, 2012). Mitochondrial and unaligned reads were 
realigned to chrM using LAST (Kielbasa et al., 2011) to identify gapped alignments 
indicative of deleted or duplicated segments. The realignment gave a coverage depth 
of 2608X and 1059X for mtDNA from the TOP3A patient and control samples, 
respectively. Split reads mapping to mtDNA were used to classify potential 
breakpoints where the breakpoints lying at 50 bases vicinity of each other were 
clustered to mark a given deletion/duplication. Segments were classified as likely 
deletions or duplications based on read orientation and overlaps with replication 
origins. Heteroplasmy was calculated as the fraction of gapped to wild type reads at a 
given breakpoint, taking the average of the two breakpoints for each altered segment.  
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2D agarose gel electrophoresis 
2D-AGE was carried out according to the method of (Reyes et al., 2009). 8 µg total 
cellular DNA was restricted with 20 U of the indicated restriction enzymes in 400 µl 
reactions for 2 hr at 37 °C. DNA was then ethanol precipitated, resuspended and 
loaded onto 0.4 % agarose without ethidium bromide. First dimension gels were run 
at 27 V for 18 hr at RT, then DNA-containing lanes were excised, rotated 90° 
counterclockwise and 1 % agarose containing 500 ng/ml ethidium bromide cast 
around the first-dimension gel slices. Second dimension gels were run at a constant 
260 mA for 6 hr at 4 °C and Southern blotted as described above. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
 
Nucleoid quantification and measurement 
Images were deconvolved with the Huygens software prior to analysis. Analysis of 
nucleoid diameter was performed on 2D confocal and g-STED images by measuring 
the full width at half maximum (FWHM, (Kukat et al., 2011)) using the Adrian’s 
FWHM plugin from ImageJ. For each nucleoid, the diameter was calculated as the 
average of FWHM measurements of X and Y axis. Analysis of nucleoids number per 
cell was performed on MAX-projections of confocal images by using the Analyze 
particles tool in ImageJ. Briefly, a region of interest (ROI) corresponding to a single 
cell was manually created and the resulting image was binarized prior to particle 
counting. Performance of the microscope and optimal depletion laser power were 
tested by using an 180ROROR multicolor nanoruler (GATTAquant, kindly provided 
by Dr. Christian Jünsgt).  Images were then analyzed in ImageJ by calculating the 
distance between the Alexa594 spots, which position was generated on the local 
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maxima. Representative pixel intensity profiles were generated in ImageJ. Image 
panels were assembled with Photoshop (Adobe). Unless otherwise stated, no other 
digital manipulation except brightness/contrast adjustment was applied. 
 
Statistical analyses for confocal and g-STED 
Statistical analyses as well as generation of frequency histogram profiles were 
performed in GraphPad Prism (San Diego, CA, USA). For nucleoids number and 
diameter analyses, significance of the differences among the RNAi conditions was 
assessed with the one-way ANOVA followed by the post-hoc Tukey test. 
 
mtDNA copy number measurements 
Band intensities from storage phosphor images of Southern blots were quantified 
using Multigauge V3.0 (Fujifilm). Copy number is expressed as the ratio of signal 
from the mitochondrial probe normalised to the level of 28S rDNA, following 
subtraction of background signal. 
 
Statistics 
Error bars are expressed as SEM. p values were calculated using the Student's t-test or 
one-way ANOVA, with the number of replicates provided in the figure legends. 
Significance thresholds used throughout the paper are * p < 0.05, ** p < 0.01, *** p < 
0.001, and **** p < 0.0001. 
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SUPPLEMENTARY FIGURE LEGENDS 
 
Figure S1 - Related to Figure 1. 
DNA from control siRNA-treated or Top3α-depleted HeLa cells was restricted using 
HincII (A) DraI (B), HindIII (C) or AccI (D) and separated by 2-dimensional agarose 
gel electrophoresis (2D-AGE) to analyse replication intermediates. Restriction maps 
(left) show the location of the probe (indicated by black bars). Interpretations of the 
structures observed are given on the right panels. The increase in signal from all 
points on the fork arc in Top3α depleted cells relative to control, in conjunction with 
the depletion of mtDNA copy number in these cells, is consistent with a genome-wide 
replication stalling phenotype. 
 
Figure S2 - Related to Figure 3. 
 (A) Uncut total DNA (3 µg) from control siRNA or Top3α siRNA treated cells was 
treated with Top2α or Top2β prior to separation on low-percentage agarose gels, then 
detected using probe (a). BamHI-treated DNA marks the migration of linear mtDNA 
and E. coli TopoI-treated DNA marks the migration of relaxed open circular form 
mtDNA. (B) Uncut total DNA (3 µg) from control siRNA or Top3α siRNA treated 
cells was treated with E. coli gyrase or E. coli TopoIV prior to separation on low-
percentage agarose gels as in (A). (C-D) Representative electron microscopy images 
of catenated mtDNA from control (C) and Top3α (D) siRNA-treated cells bound to 
E. coli SSB protein, with interpretations. Only few molecules of E. coli SSB protein 
(represented by green circles in the lower explanatory diagrams) were found bound to 
mtDNA. Scale bars, 0.5 µm. 
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Figure S3 - Related to Figure 3. 
 (A+B) Rescue of Top3α siRNA-induced mtDNA catenation phenotype. Flp-In T-
REx 293 cells were stably transfected with the wild-type (WT) or catalytically 
inactive (Y362F) TOP3A cDNA in either full length (FL) or N-terminally truncated 
(Δ15) form. The use of a recoded TOP3A construct renders the inducibly expressed 
transcripts resistant to the Top3α siRNA oligos used. Expression of the constructs 
was induced by the addition of 2 ng/ml tetracycline in control siRNA treated cells 
(lanes 1-5) or Top3α siRNA treated cells (lanes 6-10). (A) Western blot of Top3α 
depletion and expression of siRNA-resistant constructs. Expression of the full-length 
Top3α generates the shorter, mitochondrial, form of Top3α following cleavage of the 
mitochondrial targeting sequence upon mitochondrial import. Removal of the first 15 
amino acids of the Top3α protein sequence (Δ15) impairs mitochondrial targeting, 
resulting in only the longer nuclear form. β-actin is used as a loading control. (B) 
Southern blot of mtDNA from samples as in (A). Total DNA samples (3 µg) were 
restricted using BamHI, separated on agarose, blotted and detected using probe (a), 
which detects both full-length mtDNA and 7S DNA. 28S rDNA is used as a loading 
control. (C-E) Representative EM images of mtDNA from Top1mt depleted cells, 
with interpretations. (C) Monomeric open circle (1n). (D) Supercoiled monomeric 
mtDNA circle (1nsc). (E) Catenane consisting of dimeric circles. All scale bars, 200 
nm. (F) Southern blot of mtDNA from HeLa cells depleted of Top3α, Top1mt or both 
proteins simultaneously using all four different possible combinations of siRNA 
oligonucleotides. Samples were treated as in (B). 28S rDNA is used as a loading 
control. (G) Quantification of mtDNA copy number from cells depleted of Top3α and 
Top1mt as in (F). Data represent the mean of three independent experiments, 
normalised to 28S rDNA levels. 
 3 
 
Figure S4 - Related to Figure 4. 
(A) Representative images of A594 spots (GreenFireLUT) imaged with confocal and 
g-STED with different depletion lasers powers. A Gaussian Blur filter (radius 2.0) 
was applied to the final images. For each picture, pixel intensity profiles of a selected 
ROI (yellow bar, 640 nm) have been generated to show the different capability to 
resolve the two A594 spots. (B) Quantification of the distance between the two A594 
spots, measured at the indicated depletion laser powers. The dotted red line 
corresponds to the value provided by the manufacturer. Numbers of A594 spots 
analyzed per condition: 50 % = 30; 70 % = 21; 99 % = 53. Bars indicate geometric 
mean + 95 % Cl. (C) Mean size of nucleoids determined by confocal microscopy 
under the indicated siRNA conditions. (D) Frequency (%) histogram profiles of the 
diameter of nucleoids analyzed in g-STED as in Fig. 4D. 
 
Figure S5 - Related to Figure 5. 
Generation of X-shaped mtDNA intermediates from high-level expression of full-
length, catalytically-inactive Top3α. (A) Western blot of wild-type (WT) and 
catalytically inactive (Y362F) Top3α expression induced using 10 ng/ml 
tetracycline. β-actin is used as a loading control. (B) Restriction map of human 
mtDNA indicating sites of restriction enzymes used. Black bar indicates the probe. 
(C) Total DNA from parental Flp-In T-REx 293 cells, or cells expressing full-length 
wild-type (WT) or catalytically inactive (Y362F) Top3α was restricted with the 
indicated enzymes, separated on agarose, blotted and detected using probe (a). 
Additional species present in Top3α Y362F expressing cells are indicated with 
arrows. 
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Figure S6 - Related to Figure 6. 
(A-C) Neuroimaging of patient. (A) CT head demonstrated no abnormality, however 
(B) MRI head (T2 axial view) demonstrated mild cerebellar atrophy and bilateral, 
symmetrical hyperintensities within the thalami (highlighted by arrows) (C). (D) 
Clinical features of the patient with TOP3A variants, highlighting marked bilateral 
ptosis and use of frontalis muscle to elevate the eyelids. (E) Muscle histopathology 
reveals numerous COX-deficient, ragged-red fibers. Skeletal muscle sections were 
stained with hematoxylin and eosin (H&E), or investigated by enzymatic 
histochemical reactions for SDH and COX activities. In the sequential COX-SDH 
reaction, cells with normal COX activity are brown whilst those deficient in COX 
activity are blue (COX-deficient, SDH-positive). (F) Whole exome sequencing read 
coverage and depth statistics for the TOP3A patient. '#' - number, 'CCDS' – exome 
consensus coding sequence. (G) WES analysis and filtering for rare, autosomal 
recessive variants in nuclear genes involved in mitochondrial function, DNA repair, 
transcription and replication identified only compound heterozygous TOP3A variants.  
 
Figure S7 - Related to Figure 6. 
(A-C) Representative EM images of mtDNA from control human fibroblasts, with 
interpretations. (A) Monomeric open circle (1n). Scale bar, 200 nm. (B) Supercoiled 
monomeric mtDNA circle (1nsc). Scale bar, 100 nm. (C) Catenane consisting of 
dimeric circles. Scale bar, 200 nm.  
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Table S1 – Sequences for oligonucleotides used 
Primer sequences for probe synthesis 
Oligo name Sequence (5'-3') mtDNA position 
Probe (a) Fwd CTC ACC CAC TAG GAT ACC AAC 16,262 - 16,282 
Probe (a) Rev GAT ACT GCG ACA TAG GGT GC 128 - 109 
Probe (b) Fwd CCA CTC ATT CAT CGA CCT CCC 14,791 - 14,811 
Probe (b) Rev CCT AGG GGG TTG TTT GAT CCC 15,375 - 15,355 
Probe (c) Fwd GGC ACA TGC AGC GCA AGT AGG 7,588 - 7,608 
Probe (c) Rev GAC CGT AGT ATA CCC CCG GTC 8,168 - 8,148 
Probe (d) Fwd GCC ACA TCT ACC ATC ACC CTC 3,496 - 3,516 
Probe (d) Rev TAG AGT TCA GGG GAG AGT GCG 4,070 - 4,050 
28S Fwd GCC TAG CAG CCG ACT TAG AAC TGG - 
28S Rev GGG CCT CCC ACT TAT TCT ACA CCT C - 
Primer sequences for Sanger sequencing of TOP3A variants 
Oligo name Sequence (5'-3') Chr. position 
TOP3A_Ex3_Fwd TCA ACA TGC CTC AAA ATT CCT Chr17:18211587- 
18211823 TOP3A_Ex3_Rev GAA GCT CCT CCC TCT CAT TTT 
TOP3A_Ex5_Fwd GCA GCA CTT ACC AGC CTT ACA Chr17:18208415- 
18208646 TOP3A_Ex5_Rev GTC ACA CTC CAA GAG CAG CA 
Substrate oligo for EMSA (5'-3') 
ACC ACA TTA ACA ACA TAA AAC CCT CAT TCA CAC GAG AAAA CAC CCT CAT GTT 
CAT ACA CCT ATC CCC CAT TCT CCT CCT A 
  
	TABLE FOR AUTHOR TO COMPLETE 
Please upload the completed table as a separate document. Please do not add subheadings to the Key 
Resources Table. If you wish to make an entry that does not fall into one of the subheadings below, please contact 
your handling editor. 
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit polyclonal anti-Top3α Proteintech Group Cat#14525-1-AP; 
RRID: AB_2205881 
Rabbit polyclonal anti-Top1mt Sigma-Aldrich Cat#HPA001915; 
RRID: AB_1080331 
Rabbit monoclonal anti-Top2α Abcam Cat#ab52934; RRID: 
AB_883143 
Mouse monoclonal anti-Top2β Santa Cruz 
Biotechnology 
Cat#sc-25330; 
RRID: AB_628384 
Rabbit polyclonal anti-Histone H3 Abcam Cat#ab1791; RRID: 
AB_302613 
Rabbit polyclonal anti-TFAM Shi et al. (2012) 
PNAS; 109:16510-5. 
N/A 
Rabbit polyclonal anti-AIF Abcam Cat#ab1998; RRID: 
AB_302748 
Mouse monoclonal anti-β-actin (clone AC-15) Abcam Cat#ab6276; RRID: 
AB_2223210 
Mouse monoclonal anti-VDAC1/Porin Abcam Cat#ab14734; RRID: 
AB_443084 
Rabbit polyclonal anti-BLM Novus Cat#NB100-214; 
RRID: AB_10001628 
Rabbit polyclonal anti-RMI1 Proteintech Group Cat#14630-1-AP; 
RRID: AB_2301203 
Rabbit polyclonal anti-RMI2 Abcam Cat#ab122685; 
RRID: AB_11127123 
Mouse monoclonal IgM anti-DNA (clone AC-30-10) Progen Cat#61014; RRID: 
AB_1541137 
Rabbit polyclonal anti-TOM20 Santa Cruz 
Biotechnology 
Cat#sc-11415; 
RRID: AB_2207533 
Sheep anti-Mouse HRP GE Healthcare Cat#NA931; RRID: 
AB_772210 
Goat anti-Rabbit HRP Thermo Fisher Cat#31460; RRID: 
AB_228341 
Goat anti-Rabbit Atto647N Sigma-Aldrich Cat#40839; RRID: 
AB_1137669 
Goat anti-Mouse IgM Alexa Fluor 594 Thermo Fisher Cat#A-21044; RRID: 
AB_2535713 
Bacterial and Virus Strains  
Autographa californica nuclear polyhedrosis virus Clontech Cat# 631401 
XL1-Blue Competent Cells Agilent Technologies Cat#200249 
   
   
   
Biological Samples   
	Human skeletal muscle biopsy Isolated from patient 
(this paper) 
N/A 
   
   
   
   
Chemicals, Peptides, and Recombinant Proteins 
Lipofectamine RNAiMAX Thermo Fisher Cat#13778075 
Aqua-Poly/Mount Polysciences, Inc. Cat#18606 
Top3α-6His - WT, Y326F and M100V This paper N/A 
Proteinase K Thermo Fisher Cat#AM2548 
T7 endonuclease I New England Biolabs Cat#M0302 
S1 nuclease Promega Cat#M5761 
E. coli Topo I New England Biolabs Cat#M0301 
Human TopIIα Inspiralis Cat#HT201 
Human TopIIβ Inspiralis Cat#HTB201 
E. coli Gyrase Inspiralis Cat#G1001 
E. coli TopoIV Inspiralis Cat#T4001 
E. coli SSB Thermo Fisher Cat#70032Z500UG 
Critical Commercial Assays 
Mitochondria isolation kit, human Miltenyi Biotec Cat#130-094-532 
Pre-Separation Filters (20 µm) Miltenyi Biotec Cat#130-101-812 
Prime-It II Random Primer Labeling Kit Agilent Technologies Cat#300385 
HIS-Select Nickel Affinity Gel Sigma-Aldrich Cat#P6611 
Superdex 200 16/600 Gel Filtration Columns GE Healthcare Cat#28989335 
HiTrap SP HP Cation Exchange Columns GE Healthcare Cat#17115101 
HiTrap Heparin HP Columns GE Healthcare Cat#17-0406-01 
SureSelectXT Human All Exon V5 bait library 96 Agilent Cat#5190-6209 
Nextera DNA library preparation kit Illumina Cat#FC-121-1030 
Deposited Data 
   
   
   
   
   
Experimental Models: Cell Lines 
Human: HeLa cells Sahlgrenska Academy 
Cell Culture Core 
Facility 
N/A 
Human: Flp-In T-REx 293 cells Sahlgrenska Academy 
Cell Culture Core 
Facility 
N/A 
Human: patient primary fibroblasts passage 5-10 This paper N/A 
Spodoptera frugiperda: Sf9 cells Clontech 631402 
   
Experimental Models: Organisms/Strains 
   
   
	   
   
   
   
Oligonucleotides 
Primers for radiolabelled probes, see Table S1 This paper N/A 
EMSA substrate oligo, see Table S1 This paper N/A 
Top1mt Silencer Select siRNA 1 Thermo Fisher Cat#s42017 
Top1mt Silencer Select siRNA 2 Thermo Fisher Cat#s42018 
Top3α Silencer Select siRNA 1 Thermo Fisher Cat#s14310 
Top3α Silencer Select siRNA 2 Thermo Fisher Cat#s14311 
Top2α Silencer Select siRNA 1 Thermo Fisher Cat#s14307 
Top2α Silencer Select siRNA 2 Thermo Fisher Cat#s14308 
Top2β Silencer Select siRNA 1 Thermo Fisher Cat#s106 
Top2β Silencer Select siRNA 2 Thermo Fisher Cat#s107 
BLM Silencer Select siRNA 1 Thermo Fisher Cat#s1997 
BLM Silencer Select siRNA 2 Thermo Fisher Cat# s1998 
RMI1 Silencer Select siRNA 1 Thermo Fisher Cat#s36811 
RMI1 Silencer Select siRNA 2 Thermo Fisher Cat#s36812 
RMI2 Silencer Select siRNA 1 Thermo Fisher Cat#41904 
RMI2 Silencer Select siRNA 2 Thermo Fisher Cat#s41905 
AllStars Negative Control siRNA Qiagen Cat#SI03650318 
Recombinant DNA 
Plasmid: pBacPAK9 Clontech Cat#631402 
Plasmid: pBacPAK9-Top3α16-1001-6His This paper N/A 
Plasmid: pBluescript II SK(+) Stratagene Cat#212205 
Plasmid: pcDNA5 FRT/TO Thermo Fisher Cat#V652020 
Plasmid: pcDNA5 FRT/TO-Top3α  This paper N/A 
Plasmid: pOG44 Thermo Fisher Cat#V600520 
Software and Algorithms 
GraphPad Prism GraphPad Software https://www.graphpa
d.com/scientific-
software/prism/ 
ImageJ NIH https://imagej.nih.go
v/ij/ 
Adrian's FWHM plugin for ImageJ NIH https://imagej.nih.go
v/ij/plugins/fwhm/ 
MultiGauge V3.0 Fujifilm N/A 
Gatan Digital Micrograph Gatan http://www.gatan.co
m/products/tem-
analysis/gatan-
microscopy-suite-
software 
Bowtie 2 Johns Hopkins 
University 
http://bowtie-
bio.sourceforge.net/
bowtie2/index.shtml 
LAST CBRC, AIST http://last.cbrc.jp/ 
Other 
   
